Preprint Review Version 1 This version is not peer-reviewed

Development and Control of Biofilms in Diabetic Foot Infections

Version 1 : Received: 30 September 2024 / Approved: 1 October 2024 / Online: 1 October 2024 (12:56:38 CEST)

How to cite: Ray, H.; Weis, C.; Nwaeze, C.; Zhou, V.; Basu, P.; Mitra, A. Development and Control of Biofilms in Diabetic Foot Infections. Preprints 2024, 2024100061. https://doi.org/10.20944/preprints202410.0061.v1 Ray, H.; Weis, C.; Nwaeze, C.; Zhou, V.; Basu, P.; Mitra, A. Development and Control of Biofilms in Diabetic Foot Infections. Preprints 2024, 2024100061. https://doi.org/10.20944/preprints202410.0061.v1

Abstract

Diabetic foot ulcers (DFUs) are a multifactorial pathophysiologic condition that occurs in patients with diabetes mellitus (DM). Approximately 9.1 to 26.1 million people are affected by DFUs annually. This condition can lead to progressive foot infections and, ultimately, foot amputation. Various microbes contribute to DFUs, including methicillin-resistant Staphylococcus. aureus, Pseudomonas aeruginosa, and Escherichia coli can form biofilms composed of complex matrices that create a protective shield around the microorganisms, enhancing their survival and resistance to treatment. Biofilm formation is a critical virulence factor directly associated with the onset and persistence of DFUs. It not only complicates the clinical management of these ulcers but also facilitates antibiotic resistance, necessitating a comprehensive approach to treatment. Effective management strategies must therefore target biofilm formation and the virulence factors associated with these pathogens. By addressing these elements, conventional antibiotics can be rendered more effective in treating diabetic foot ulcers. This approach aims not only to promote wound healing but also to address underlying causes and prevent further complications. This article seeks to highlight the significance of biofilm formation in DFUs, explore methodologies for studying this condition, as well as discuss demographic considerations and treatment options.

Keywords

Diabetic Foot Ulcers; DFU; Diabetic Foot Infections; DFI; Biofilm; Recalcitrant Wounds; Multidrug resistance; Antimicrobial Resistance

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.